Olga Anatolyevna Lobacheva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Olga Anatolyevna Lobacheva has a total of 70 co-authors. Here are the top co-authors by number of shared publications:
- Valentina Borisovna Nikitina
Tomsk National Research Medical Center, Russian Academy of Sciences, Mental Health Research Institute
11 shared publications - Tamara Parfenovna Vetlugina
Mental Health Research Institute, Tomsk National Research Medical Center (NRMC), Russian Academy of Sciences
10 shared publications - Elena G. Kornetova
Mental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences
8 shared publications - Arkady Valentinovich Semke
Mental Health Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, 634014 Tomsk, Russia
6 shared publications - Nikolay Aleksandrovich Bokhan
Mental Health Research Institute — Tomsk National Research Medical Center Russian Academy of Sciences
6 shared publications T.P. Vetlugina
6 shared publications
Latest Publications
- 14 July 2026
- Published by Mental Health Research Institute in Сибирский вестник психиатрии и наркологии
- No. 2(131)
Markers of immune inflammation in clinical polymorphism of schizophrenia
- 14 July 2026
- Published by Mental Health Research Institute in Сибирский вестник психиатрии и наркологии
- No. 2(131)
Markers of immune inflammation in clinical polymorphism of schizophrenia
- 25 May 2026
- Published by ECO-Vector LLC (Publications) in Neurology Bulletin
- Vol. LVIII (2) , 295-303
Association of prolactin levels with social adaptation in patients with schizophrenia
BACKGROUND: Despite the proven role of antipsychotics in inducing hyperprolactinemia, data on its effect on long-term social adaptation in patients with schizophrenia are limited, particularly in subgroups with different schizophrenia course types. AIM: To examine the associations between serum prolactin levels and a quantitative self-reported measure of social adaptation in patients with schizophrenia. METHODS: We examined 91 patients with schizophrenia (36 men and 55 women) of Slavic ethnicity. Prolactin levels were determined by enzyme immunoassay using the PRL Test System kit (Monobind Inc., USA) for quantitative serum prolactin measurement. Social adaptation was assessed using the SASS self-report questionnaire, adapted for studying social functioning in patients with schizophrenia. Statistical analysis was performed using Statistica for Windows V.12.0 (Statsoft). Qualitative data are presented as frequencies in absolute and relative units, n (%). Quantitative data were compared using the Kruskal–Wallis test. The frequency distribution of qualitative variables was assessed using the Pearson χ² test with Yates correction and Fisher exact test. RESULTS: Hyperprolactinemia was diagnosed in 70 patients (76.9%), and normal prolactin levels were recorded in 21 (23.1%). According to the SASS questionnaire, social maladjustment was found in 8 patients (8.8%), difficult social adaptation in 32 (35.2%), and normal social adaptation in 51 (56.0%). The highest prolactin levels were seen in patients with normal social adaptation, and the lowest in patients with severe maladjustment (p = 0.001). However, analysis of the frequency of different social adaptation levels in patients with and without hyperprolactinemia showed no statistically significant difference (p = 0.157). CONCLUSION: The highest prolactin levels were found in patients with normal social adaptation, and the lowest in those with severe social maladjustment. These findings may support the development of treatment protocols that minimize endocrine side effects and optimize social reintegration.
- 25 May 2026
- Published by ECO-Vector LLC (Publications) in Neurology Bulletin
- Vol. LVIII (2) , 295-303
Association of prolactin levels with social adaptation in patients with schizophrenia
BACKGROUND: Despite the proven role of antipsychotics in inducing hyperprolactinemia, data on its effect on long-term social adaptation in patients with schizophrenia are limited, particularly in subgroups with different schizophrenia course types. AIM: To examine the associations between serum prolactin levels and a quantitative self-reported measure of social adaptation in patients with schizophrenia. METHODS: We examined 91 patients with schizophrenia (36 men and 55 women) of Slavic ethnicity. Prolactin levels were determined by enzyme immunoassay using the PRL Test System kit (Monobind Inc., USA) for quantitative serum prolactin measurement. Social adaptation was assessed using the SASS self-report questionnaire, adapted for studying social functioning in patients with schizophrenia. Statistical analysis was performed using Statistica for Windows V.12.0 (Statsoft). Qualitative data are presented as frequencies in absolute and relative units, n (%). Quantitative data were compared using the Kruskal–Wallis test. The frequency distribution of qualitative variables was assessed using the Pearson χ² test with Yates correction and Fisher exact test. RESULTS: Hyperprolactinemia was diagnosed in 70 patients (76.9%), and normal prolactin levels were recorded in 21 (23.1%). According to the SASS questionnaire, social maladjustment was found in 8 patients (8.8%), difficult social adaptation in 32 (35.2%), and normal social adaptation in 51 (56.0%). The highest prolactin levels were seen in patients with normal social adaptation, and the lowest in patients with severe maladjustment (p = 0.001). However, analysis of the frequency of different social adaptation levels in patients with and without hyperprolactinemia showed no statistically significant difference (p = 0.157). CONCLUSION: The highest prolactin levels were found in patients with normal social adaptation, and the lowest in those with severe social maladjustment. These findings may support the development of treatment protocols that minimize endocrine side effects and optimize social reintegration.
- Open Access
- 23 September 2025
- Published by FSPSI SCFHHRP in Acta Biomedica Scientifica
- Vol. 10 (4) , 171-181
Predicting the risk of the formation of mixed anxiety and depressive disorders in women
Background. In case of unfavorable dynamics of events and/or untimely treatment; adjustment disorders may develop into more severe conditions with aggravated clinical manifestations. The reaction to stress becomes prolonged and goes beyond the adjustment disorders; leading to the formation of stable psychopathological disorders with a predominance of vegetative symptoms. A mixed anxiety and depressive reaction due to adjustment disorders may transform into a clinically formalized mixed anxiety and depressive disorder.The aim. Construction of a mathematical model for predicting the risk of developing the mixed anxiety and depressive disorder in women with mixed anxiety and depressive reaction due to adjustment disorders; using hormonal parameters.Materials and methods. Two groups of women were examined: group 1 (n = 53) with the diagnosis of “Adjustment disorders: mixed anxiety and depressive reaction” (F43.22); group 2 (n = 48) – “Mixed anxiety and depressive disorder” (F41.2). The level of anxiety was determined using the Spielberger – Khanin Personality and Reactive Anxiety subscale. Anxiety and depression levels were assessed using the Hospital Anxiety and Depression Scale (HADS). The body mass index (BMI) was calculated. The laboratory study included the determination of hormonal parameters using the ELISA method. All data were processed statistically.Results. A model for predicting the risk of developing mixed anxiety and depressive disorder in women with mixed anxiety and depressive reaction due to adjustment disorder had been developed. The model included the level of cortisol; prolactin; and BMI. The criterion variable was calculated; and if its value was ≥ 1.5; the risk of developing mixed anxiety and depressive disorder was predicted; and if the value was < 1.5; a favorable course of adjustment disorder was predicted with 83.0 % sensitivity – 81.3 % specificity.Conclusion. We propose a mathematical model that provides the possibility of early recognition of conditions with a high risk of developing mixed anxiety and depressive disorder. This will allow timely carrying out the preventive and therapeutic activities aimed at increasing the stress resistance and restoring the normal neuroendocrine regulation.
- 23 September 2025
- Published by FSPSI SCFHHRP in Acta Biomedica Scientifica
- Vol. 10 (4) , 171-181
Open AccessPredicting the risk of the formation of mixed anxiety and depressive disorders in women
Background. In case of unfavorable dynamics of events and/or untimely treatment; adjustment disorders may develop into more severe conditions with aggravated clinical manifestations. The reaction to stress becomes prolonged and goes beyond the adjustment disorders; leading to the formation of stable psychopathological disorders with a predominance of vegetative symptoms. A mixed anxiety and depressive reaction due to adjustment disorders may transform into a clinically formalized mixed anxiety and depressive disorder.The aim. Construction of a mathematical model for predicting the risk of developing the mixed anxiety and depressive disorder in women with mixed anxiety and depressive reaction due to adjustment disorders; using hormonal parameters.Materials and methods. Two groups of women were examined: group 1 (n = 53) with the diagnosis of “Adjustment disorders: mixed anxiety and depressive reaction” (F43.22); group 2 (n = 48) – “Mixed anxiety and depressive disorder” (F41.2). The level of anxiety was determined using the Spielberger – Khanin Personality and Reactive Anxiety subscale. Anxiety and depression levels were assessed using the Hospital Anxiety and Depression Scale (HADS). The body mass index (BMI) was calculated. The laboratory study included the determination of hormonal parameters using the ELISA method. All data were processed statistically.Results. A model for predicting the risk of developing mixed anxiety and depressive disorder in women with mixed anxiety and depressive reaction due to adjustment disorder had been developed. The model included the level of cortisol; prolactin; and BMI. The criterion variable was calculated; and if its value was ≥ 1.5; the risk of developing mixed anxiety and depressive disorder was predicted; and if the value was < 1.5; a favorable course of adjustment disorder was predicted with 83.0 % sensitivity – 81.3 % specificity.Conclusion. We propose a mathematical model that provides the possibility of early recognition of conditions with a high risk of developing mixed anxiety and depressive disorder. This will allow timely carrying out the preventive and therapeutic activities aimed at increasing the stress resistance and restoring the normal neuroendocrine regulation.
- Open Access
- 14 July 2025
- Published by Siberian State Medical University in Bulletin of Siberian Medicine
- Vol. 24 (2) , 59-65
The relationship of hormones of the hypothalamic – pituitary – thyroid axis with cognitive impairment in patients with schizophrenia
Aim. To study the relationship of serum fT3, fT4, and TSH levels with cognitive impairment in patients with schizophrenia.Materials and methods. The study included 74 patients with schizophrenia. Socio-demographic and clinical data were collected, the severity of psychopathological symptoms was assessed using PANSS, and cognitive functions were evaluated using BACS. Serum levels of fT3, fT4, and TSH in patients were determined using enzyme immunoassay kits.Results. In the group of men with schizophrenia, a negative correlation was found between the concentration of fT3 and verbal fluency (rs = –0.325; p = 0.033), whereas in women, a positive correlation was found between the concentration of fT4 and motor skills (rs = 0.372; p = 0.039).Conclusion. The study revealed a linear relationship between thyroid hormones and cognitive impairment in patients with schizophrenia, but the nature of the relationship found differed in men and women. The results of the study confirm the need for regular dynamic monitoring of thyroid hormone levels in patients with schizophrenia in order to prevent the progression of cognitive impairment.
- 14 July 2025
- Published by Siberian State Medical University in Bulletin of Siberian Medicine
- Vol. 24 (2) , 59-65
Open AccessThe relationship of hormones of the hypothalamic – pituitary – thyroid axis with cognitive impairment in patients with schizophrenia
Aim. To study the relationship of serum fT3, fT4, and TSH levels with cognitive impairment in patients with schizophrenia.Materials and methods. The study included 74 patients with schizophrenia. Socio-demographic and clinical data were collected, the severity of psychopathological symptoms was assessed using PANSS, and cognitive functions were evaluated using BACS. Serum levels of fT3, fT4, and TSH in patients were determined using enzyme immunoassay kits.Results. In the group of men with schizophrenia, a negative correlation was found between the concentration of fT3 and verbal fluency (rs = –0.325; p = 0.033), whereas in women, a positive correlation was found between the concentration of fT4 and motor skills (rs = 0.372; p = 0.039).Conclusion. The study revealed a linear relationship between thyroid hormones and cognitive impairment in patients with schizophrenia, but the nature of the relationship found differed in men and women. The results of the study confirm the need for regular dynamic monitoring of thyroid hormone levels in patients with schizophrenia in order to prevent the progression of cognitive impairment.
- Open Access
- 14 April 2025
- Published by Siberian State Medical University in Bulletin of Siberian Medicine
- Vol. 24 (1) , 45-51
The impact of the hypothalamic-pituitary-thyroid axis hormone levels on suicide risk in patients with schizophrenia
Aim. To assess the impact of thyroid stimulating hormone (TSH), free triiodothyronine (FT3) and free thyroxine (FT4) concentrations in the blood serum of patients with schizophrenia with suicide risk. Materials and methods. A total of 120 patients with schizophrenia (75 women and 45 men) were examined. Suicide risk was assessed using the Beck Hopelessness Scale (BHS). Serum levels of FT3, FT4 and TSH in patients with schizophrenia were determined using enzyme immunoassay kits. Multiple linear regression analysis and single-factor analysis of variance (ANOVA) were used to identify the relationships between the studied indicators. Results. Among 120 patients with schizophrenia, 11 patients (9.2%) had elevated serum TSH values (> 4.0 mME/L), 108 (90%) had decreased FT3 levels, (< 4.0 pmol/L), 42 (35%) had decreased FT4 levels (< 10.3 pmol/L). The study revealed statistically significant differences in the level of hopelessness between the groups of patients with normal and elevated TSH (F (1.118) = 5.160, p = 0.025), as well as with normal and decreased FT3 (F (1.118) = 4.568, p = 0.035). Conclusion. It was found that TSH and FT3 concentrations in blood serum significantly affect the level of hopelessness assessed using the Beck scale in patients with schizophrenia. The results of this study confirm the need for regular dynamic monitoring of hormone levels of the hypothalamic-pituitary-thyroid axis in patients with schizophrenia in order to maintain its normal functioning, as well as prevent adverse effects in the form of suicide attempts and suicide.
- 14 April 2025
- Published by Siberian State Medical University in Bulletin of Siberian Medicine
- Vol. 24 (1) , 45-51
Open AccessThe impact of the hypothalamic-pituitary-thyroid axis hormone levels on suicide risk in patients with schizophrenia
Aim. To assess the impact of thyroid stimulating hormone (TSH), free triiodothyronine (FT3) and free thyroxine (FT4) concentrations in the blood serum of patients with schizophrenia with suicide risk. Materials and methods. A total of 120 patients with schizophrenia (75 women and 45 men) were examined. Suicide risk was assessed using the Beck Hopelessness Scale (BHS). Serum levels of FT3, FT4 and TSH in patients with schizophrenia were determined using enzyme immunoassay kits. Multiple linear regression analysis and single-factor analysis of variance (ANOVA) were used to identify the relationships between the studied indicators. Results. Among 120 patients with schizophrenia, 11 patients (9.2%) had elevated serum TSH values (> 4.0 mME/L), 108 (90%) had decreased FT3 levels, (< 4.0 pmol/L), 42 (35%) had decreased FT4 levels (< 10.3 pmol/L). The study revealed statistically significant differences in the level of hopelessness between the groups of patients with normal and elevated TSH (F (1.118) = 5.160, p = 0.025), as well as with normal and decreased FT3 (F (1.118) = 4.568, p = 0.035). Conclusion. It was found that TSH and FT3 concentrations in blood serum significantly affect the level of hopelessness assessed using the Beck scale in patients with schizophrenia. The results of this study confirm the need for regular dynamic monitoring of hormone levels of the hypothalamic-pituitary-thyroid axis in patients with schizophrenia in order to maintain its normal functioning, as well as prevent adverse effects in the form of suicide attempts and suicide.
- 20 November 2023
- Published by Taylor & Francis in Journal of Ethnicity in Substance Abuse
- Vol. 23 (3) , 569-585
Hormones, oxidized proteins, and lipids in alcoholism. Duration of remission
The instability of remission in alcohol dependence (AD) creates a need to search for criteria for predicting its duration. The aim of study was to determine the hormones, oxidized proteins, and lipids in patients with AD, and the possible relations between these parameters and the duration of remission. Blood samples were obtained from 49 male patients with AD after alcohol detoxification (Total group). Two groups of patients were formed: with unstable therapeutic remission up to 6 months (UTR-group); with stable therapeutic remission which lasted 12 months or longer (STR-group). The control group comprised men without AD. The levels of carbonylated proteins (CP), lipid peroxidation (TBA-RS) were determined in the blood plasma. The levels of cortisol, testosterone total, thyroid-stimulating hormone (TSH), triiodothyronine free (fT3), and thyroxine free (fT4) in the blood serum were measured. The Total group of patients showed an increase in CP, TBA-RS, Cortisol, cortisol/testosterone ratio, and a decrease in TSH, fT3, and fT3/fT4 levels. A set of parameters (T, fT3, fT4, cortisol/testosterone ratio) associated with unstable remission was identified.
- 20 November 2023
- Published by Taylor & Francis in Journal of Ethnicity in Substance Abuse
- Vol. 23 (3) , 569-585
Hormones, oxidized proteins, and lipids in alcoholism. Duration of remission
The instability of remission in alcohol dependence (AD) creates a need to search for criteria for predicting its duration. The aim of study was to determine the hormones, oxidized proteins, and lipids in patients with AD, and the possible relations between these parameters and the duration of remission. Blood samples were obtained from 49 male patients with AD after alcohol detoxification (Total group). Two groups of patients were formed: with unstable therapeutic remission up to 6 months (UTR-group); with stable therapeutic remission which lasted 12 months or longer (STR-group). The control group comprised men without AD. The levels of carbonylated proteins (CP), lipid peroxidation (TBA-RS) were determined in the blood plasma. The levels of cortisol, testosterone total, thyroid-stimulating hormone (TSH), triiodothyronine free (fT3), and thyroxine free (fT4) in the blood serum were measured. The Total group of patients showed an increase in CP, TBA-RS, Cortisol, cortisol/testosterone ratio, and a decrease in TSH, fT3, and fT3/fT4 levels. A set of parameters (T, fT3, fT4, cortisol/testosterone ratio) associated with unstable remission was identified.
- 30 August 2022
- Published by Mental Health Research Institute in Сибирский вестник психиатрии и наркологии
- No. 2(115)
Показатели врожденного иммунитета – особенности диагностики тревожных расстройств у женщин
- 30 August 2022
- Published by Mental Health Research Institute in Сибирский вестник психиатрии и наркологии
- No. 2(115)
Показатели врожденного иммунитета – особенности диагностики тревожных расстройств у женщин